we hit 18c recently. We now have a drug with 10 years exclusivity heading to Ph3 and validates the capacity of the firm to develop the products mentioned in recent UQ research. Mad time to sell at that price
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-107
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.015(3.70%) |
Mkt cap ! $716.5M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.5¢ | 38.5¢ | $646.0K | 1.636M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 320447 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 70131 | 5 |
View Market Depth
| Last trade - 11.15am 01/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |